Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients

Data regarding the durability of tenofovir alafenamide (TAF)-containing antiretroviral therapy (ART) in maintaining hepatitis B virus (HBV) viral suppression among HIV/HBV-coinfected patients are limited. Between February and October 2018, 274 HIV/HBV-coinfected participants who had achieved HIV RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu-Shan, Cheng, Chien-Yu, Sun, Hsin-Yun, Cheng, Shu-Hsing, Lu, Po-Liang, Lee, Chen-Hsiang, Lee, Yuan-Ti, Tsai, Hung-Chin, Yang, Chia-Jui, Liu, Chun-Eng, Liou, Bo-Huang, Lin, Shih-Ping, Huang, Sung-Hsi, Ho, Mao-Wang, Tang, Hung-Jen, Hung, Chien-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269761/
https://www.ncbi.nlm.nih.gov/pubmed/36988457
http://dx.doi.org/10.1128/spectrum.05125-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269761/
https://www.ncbi.nlm.nih.gov/pubmed/36988457
http://dx.doi.org/10.1128/spectrum.05125-22

Ejemplares similares